Literature DB >> 17451814

Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Doris Lambracht-Washington1, Kevin C O'Connor, Elizabeth M Cameron, Andrea Jowdry, E Sally Ward, Elliot Frohman, Michael K Racke, Nancy L Monson.   

Abstract

We re-engineered the immunoglobulin rearrangements from clonally expanded CSF B cells of three Multiple Sclerosis patients as Fab fragments, and used three methods to test for their antigen (Ag) specificity. Nine out of ten Fab fragments were reactive to Myelin Basic Protein (MBP). The one Fab that did not react to MBP was a product of receptor editing. Two of the nine MBP reactive Fabs were also reactive to GFAP and CNPase, indicating that these clones were polyreactive. Targeting the mechanisms that allow these self-reactive B cells to reside in the CSF of MS patients may prove to be a potent immunotherapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451814      PMCID: PMC2709235          DOI: 10.1016/j.jneuroim.2007.03.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  73 in total

Review 1.  Receptor editing in positive and negative selection of B lymphopoiesis.

Authors:  Efrat Edry; Doron Melamed
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

2.  Amino acid sequence of the encephalitogenic basic protein from human myelin.

Authors:  P R Carnegie
Journal:  Biochem J       Date:  1971-06       Impact factor: 3.857

3.  pUR222, a vector for cloning and rapid chemical sequencing of DNA.

Authors:  U Rüther; M Koenen; K Otto; B Müller-Hill
Journal:  Nucleic Acids Res       Date:  1981-08-25       Impact factor: 16.971

4.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

5.  Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype.

Authors:  D G Ando; J Clayton; D Kono; J L Urban; E E Sercarz
Journal:  Cell Immunol       Date:  1989-11       Impact factor: 4.868

Review 6.  2',3'-cyclic nucleotide 3'-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system.

Authors:  T J Sprinkle
Journal:  Crit Rev Neurobiol       Date:  1989

7.  Cross-linking studies on the conformation and dimerization of myelin basic protein in solution.

Authors:  E E Golds; P E Braun
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

8.  Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS.

Authors:  C H Chou; W W Tourtellotte; R F Kibler
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

Review 9.  Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis.

Authors:  George Harauz; Noboru Ishiyama; Christopher M D Hill; Ian R Bates; David S Libich; Christophe Farès
Journal:  Micron       Date:  2004       Impact factor: 2.251

10.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  23 in total

1.  Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Authors:  F J Quintana; M F Farez; G Izquierdo; M Lucas; I R Cohen; H L Weiner
Journal:  Neurology       Date:  2012-01-18       Impact factor: 9.910

2.  MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.

Authors:  William H Rounds; Edward A Salinas; Tom B Wilks; Mikhail K Levin; Ann J Ligocki; Carolina Ionete; Carlos A Pardo; Steven Vernino; Benjamin M Greenberg; Douglas W Bigwood; Eric M Eastman; Lindsay G Cowell; Nancy L Monson
Journal:  Gene       Date:  2015-07-11       Impact factor: 3.688

Review 3.  The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Authors:  Martin Stangel; Sten Fredrikson; Edgar Meinl; Axel Petzold; Olaf Stüve; Hayrettin Tumani
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

Review 4.  B cells in multiple sclerosis: connecting the dots.

Authors:  H-Christian von Büdingen; Amit Bar-Or; Scott S Zamvil
Journal:  Curr Opin Immunol       Date:  2011-10-07       Impact factor: 7.486

5.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

6.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

7.  Atacicept: targeting B cells in multiple sclerosis.

Authors:  Hans-Peter Hartung; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

Review 8.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

9.  Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Authors:  Elizabeth M Cameron; Sade Spencer; Jonathan Lazarini; Christopher T Harp; E Sally Ward; Mark Burgoon; Gregory P Owens; Michael K Racke; Jeffrey L Bennett; Elliot M Frohman; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2009-07-24       Impact factor: 3.478

10.  Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.

Authors:  David A Lyons; Stephen G Naylor; Anja Scholze; William S Talbot
Journal:  Nat Genet       Date:  2009-06-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.